Baxter International’s divestiture and 2025 outlook could mark a new chapter after years of decline and missed expectations.

Shares of Baxter International Inc. BAX rose 2.64% to $30.72 Wednesday, on what proved to be an all-around favorable trading ...

This was the stock's second consecutive day of losses.

The Q1 equity market saw a sharp rotation from growth to value stocks, driven by policy uncertainty and the DeepSeek AI model ...

Baxter International, a prominent health care and pharmaceutical manufacturer, reports that President Trump's tariffs will ...

Tariffs will likely cost Deerfield-based Baxter International $60 million to $70 million this year, the company’s chief financial officer said in an earnings call Thursday.

I would now like to turn the call over to Ms. Clare Trachtman, Senior Vice President, Chief Investor Relations Officer at Baxter International. Ms. Trachtman, you may begin. Good morning ...

Second-Quarter 2025 EPS Guidance: $0.59 to $0.63. Baxter International Inc (NYSE:BAX) exceeded its first-quarter guidance on both the top and bottom lines, showcasing strong financial performance.

England winger Immanuel Feyi-Waboso could be fit for the summer international tours, says Exeter boss Rob Baxter.

Baxter International, a prominent healthcare and pharmaceutical manufacturer, reports that President Trump's tariffs will likely cost the company $60 million to $70 million this year. Baxter makes a ...

With a market cap of $15.6 billion, Baxter International Inc. (BAX) is a global healthcare company that specializes in ...

The Trump administration has not yet imposed tariffs on pharmaceuticals, but is now investigating how imports of ...